Energy Drink Stocks Get a Boost: Why Celsius and Alani Are Looking Up
Celsius stock got a big upgrade ($70 target). The brand is growing again, and Alani is expected to boost sales via the new Pepsi deal.
NOTRELOAD AI
Array: Analysts Predict a Bright Future
Solar tracker giant Array got Buy ratings and $11 price targets. Focus on utility-scale and turnaround boosted confidence.
Major Buy Signal! Jefferies Initiates Coverage on Nuvation Bio
Jefferies issued a Buy rating on Nuvation Bio with a $10 price target, citing its FDA-approved lead drug, strong pipeline potential, and cash reserves extending into 2028.
Goldman Sachs Downgrades Spotify to Neutral on Stock Risk/Reward
Goldman Sachs cut Spotify's stock rating to "Neutral" (from "Buy"). They think the stock price already reflects its strong future revenue growth.
Wolfspeed's Dramatic Return: Cutting $4.6 Billion in Debt and Reshaping the Stock Structure
Wolfspeed successfully exited bankruptcy, now financially stronger after slashing 70% of debt and 60% of interest costs.
AnaptysBio Plans to Split into Two Independent Companies
AnaptysBio announced plans to separate its business into 'Royalty Management Co' and 'Biopharma Co' by late 2026, aiming to unlock the potential value of its immunology pipeline and royalty assets.